Contineum Therapeutics, Inc Class A Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $242 | $0 |
Gross Profit | -79 | 121 | ||
EBITDA | -15,961 | -18,032 | -14,490 | -10,205 |
EBIT | -16,040 | -18,110 | -14,565 | -10,267 |
Net Income | -16,040 | -15,990 | -14,565 | -10,267 |
Net Change In Cash | 0 | 0 | 242 | 0 |
Free Cash Flow | -15,705 | -14,459 | -10,368 | -6,251 |
Cash | 20,784 | 22,470 | 21,943 | 40,891 |
Basic Shares | 25,895 | 25,868 | 25,854 | 25,730 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $50,000 | $0 | $0 |
Gross Profit | 50,000 | -329 | ||
EBITDA | -42,000 | 23,573 | -23,536 | -28,336 |
EBIT | -42,258 | 23,378 | -23,865 | -28,661 |
Net Income | -42,258 | 22,720 | -24,253 | -29,001 |
Net Change In Cash | 0 | 50,000 | 0 | 0 |
Free Cash Flow | -33,359 | 18,935 | -20,239 | -26,434 |
Cash | 21,943 | 15,526 | 5,569 | 4,630 |
Basic Shares | 19,352 | 25,278 | 25,130 | 25,130 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.62 |
2025-03-31 | -$0.62 |
2024-12-31 | -$0.56 |
